WAT

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Terry SmithFundsmith $957M3.2M shares TrimQ1 2026 $395M $319.54 $342.18

Congress Trades

Actor	Trade Size	Last Transaction	Amount Range	Price	Current Price
Ro KhannaDemocrat $8.0k24.6 shares BuyApr 13, 2026 $1k-$15k $324.68 $342.18
Thomas H. KeanRepublican $8.0k26.7 shares SellMar 10, 2026 $1k-$15k $299.63 $342.18
Thomas H. KeanRepublican $8.0k24.7 shares SellFeb 13, 2026 $1k-$15k $323.37 $342.18
Debbie DingellDemocrat $8.0k24.5 shares OtherFeb 10, 2026 $1k-$15k $327.02 $342.18
Kevin HernRepublican $8.0k24.4 shares OtherFeb 9, 2026 $1k-$15k $328.14 $342.18
Julia LetlowRepublican $8.0k20.4 shares BuyDec 8, 2025 $1k-$15k $392.75 $342.18

News

prnewswire.comWaters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysisprnewswire.comJun 9

prnewswire.comWaters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysisprnewswire.comJun 8

zacks.comWhy Is Waters (WAT) Up 8.7% Since Last Earnings Report?zacks.comJun 4

seekingalpha.comWaters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 3

prnewswire.comWaters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnosticsprnewswire.comJun 3

Trade WAT

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

CEO: Udit Batra
IPO Date: Nov 17, 1995

Market Data

Open: $372.68
High: $376.35
Low: $363.61
Volume: 671.2K
52W High: $414.15
52W Low: $275.05

Valuation

Market Cap: $24B
Enterprise Value: $29B

Financials

Free Cash Flow: $540M
Revenue: $3.2B
Net Income: $643M
Cash: $588M
Debt: $1.5B

Events

EarningsAug 3

EPS est. 3